Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Psychiatric disorder topiramate

In a retrospective chart review, weight loss was assessed in 214 patients with psychiatric disorders taking topiramate (1128). Patients taking either lithium or valproate gained a mean (SD) of 6.3 (9.0) kg and 6.4 (9.0) kg respectively, whereas patients taking topiramate lost 1.2 (6.3) kg. Similar statistically significant results were found in the bone mass index. [Pg.652]

The authors discussed the hypothesis of a coincidental finding as well as the development of an alternative psychosis but finally attributed the patient s psychiatric disorder to topiramate. [Pg.697]

Calabrese JR. Update on the use of topiramate in bipolar disorder. Presented at the American Psychiatric Association 2000 Annual Meeting, Chicago, May 13-18, 2000. [Pg.222]

The prevalence of psychiatric adverse events in relation to topiramate has been studied in 431 consecutive patients (648). There were psychiatric adverse events in 103 patients (24%), including affective disorder in 46 (11%),... [Pg.697]

Topiramate has been associated with several psychiatric adverse events, such as nervousness, depression, behavioral problems, mood lability, and psychosis. Obsessive-compulsive disorder has also been reported (650). [Pg.697]


See other pages where Psychiatric disorder topiramate is mentioned: [Pg.8]    [Pg.697]    [Pg.3447]    [Pg.127]    [Pg.165]    [Pg.167]    [Pg.651]    [Pg.651]    [Pg.696]    [Pg.277]    [Pg.277]    [Pg.3450]    [Pg.1154]   


SEARCH



Psychiatric disorders

Topiramate

Topiramate psychiatric

© 2024 chempedia.info